RBL Bank is a private-sector bank with retail, wholesale, credit-card, microfinance and treasury businesses, entering its first full quarter after Emirates NBD's infusion of approximately USD 2.75 Bn made it the promoter with 60% of expanded share capital. The print will speak to whether the guided 30-40 bps NIM improvement and the 1% ROA target for the Q2/Q3 FY27 timeframe materialise, and whether elevated credit-card slippages begin to moderate.
| Results date | October 12, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter NII | Rs. 1,654 Cr (Q1 FY27, up 12% YoY) |
| Previous quarter PAT | Rs. 254 Cr (Q1 FY27, up 27% YoY and 10% QoQ) |
| Previous quarter NIM | 4.13% (Q1 FY27) |
| Market cap | Rs. 64,342.07 Cr |
| CMP | Rs. 414.5 |
Board meeting scheduled for October 12 to consider Q2/H1 FY27 unaudited results, with limited review by joint statutory auditors; trading window closed until October 14.
Separately, the bank's FY26 final dividend of Rs. 1.00 per share was declared at the 83rd AGM held on September 2, 2026, with August 14, 2026 as record date and payment on or before October 1, 2026. This relates to FY26 and is not part of the Q2 FY27 results agenda.
The quarter's central test is whether RBL Bank converts the Emirates NBD capital infusion into returns, with management having guided ROA to the 1% mark in the Q2/Q3 FY27 timeframe from 0.57% in Q1 FY27. On the provisional October 5 business update, deposits stood at Rs. 1,562.8 Bn, up 34% YoY and 25% QoQ, and gross advances at Rs. 1,433.5 Bn, up 40% YoY and 22% QoQ, with core advances growth of 30% YoY excluding international banking unit loans against FCNR(B) deposits. Management guided a 30-40 bps NIM improvement in Q2 from the equity infusion, after retiring approximately Rs. 10,000 Cr of high-cost wholesale borrowings at a net rate of 7.25% and holding surplus liquidity in short-term instruments yielding 6.7%-6.8%; the CASA ratio slipping to 27.2% from 29.2% in June 2026 is a partial offset. On asset quality, GNPA of 1.30% and NNPA of 0.37% in Q1 FY27 were the best in recent history with credit cost at 54 bps, though management expects card and personal-loan slippages to remain elevated in H1 FY27 before a sharp reduction from Q3 FY27. The upcoming call is also expected to cover the cost-to-income trajectory, which management guided down another 5-6 points from about 64% over the next one to two quarters, and the pending RBI approval for the amalgamation of ENBD's India branch into the bank.
Performance vs guidance tracking: Management has multiple standing guidance markers that the Q2 FY27 print and call will be measured against.
Provisional Q2 balance-sheet reconciliation
ENBD integration and capital deployment
Asset quality and coverage detail
Management said the full impact of the capital infusion would be visible in Q2 and Q3 FY27 and expects ROA to reach the 1% mark in that timeframe. ROA was 0.57% in Q1 FY27.
Executive Director Jaideep Iyer said he would "hesitate to go beyond Q2", citing a move toward lower-risk loans and possible deployment of excess liquidity into lower-yielding assets. Management guided a 30-40 bps NIM improvement in Q2 from the equity infusion.
Management said card and personal-loan slippages would remain elevated in H1 FY27 with a sharp reduction expected from Q3 FY27. It cited material declines in early delinquency flows into 10-day and 30-day buckets as the basis for that expectation.
ENBD infused approximately USD 2.75 Bn (INR 260 Bn) through a preferential issue at Rs. 280 per share for 60% of expanded share capital, becoming a promoter. Q1 FY27 capital adequacy stood at 33.3% with CET-1 at 32.2%, and the amalgamation of ENBD's India branch remains pending RBI approval.
Management said reported LDR was around 93% in Q1 FY27, but around 66% when long-term borrowings and capital were included. It said it was not seriously tracking a scenario above 100%.